|
1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2019. CA Cancer J Clin. 69:7–34. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lin JJ, Cardarella S, Lydon CA, Dahlberg
SE, Jackman DM, Jänne PA and Johnson BE: Five-year survival in
EGFR-mutant metastatic lung adenocarcinoma treated with EGFR-TKIs.
J Thorac Oncol. 11:556–565. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Memczak S, Jens M, Elefsinioti A, Torti F,
Krueger J, Rybak A, Maier L, Mackowiak SD, Gregersen LH, Munschauer
M, et al: Circular RNAs are a large class of animal RNAs with
regulatory potency. Nature. 495:333–338. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
He J, Xie Q, Xu H, Li J and Li Y: Circular
RNAs and cancer. Cancer Lett. 396:138–144. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wu G, Zhou W, Pan X, Sun Z, Sun Y, Xu H,
Shi P, Li J, Gao L and Tian X: Circular RNA profiling reveals
exosomal circ_0006156 as a novel biomarker in papillary thyroid
cancer. Mol Ther Nucleic Acids. 19:1134–1144. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fan L, Wang J, Cao Q, Ding X and Li B:
Aberrant miR-1246 expression promotes radioresistance in non-small
cell lung cancer: A potential prognostic biomarker and radiotherapy
sensitization target. Am J Cancer Res. 10:314–335. 2020.PubMed/NCBI
|
|
8
|
Lei B, Tian Z, Fan W and Ni B: Circular
RNA: A novel biomarker and therapeutic target for human cancers.
Int J Med Sci. 16:292–301. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cheng X, Qiu J, Wang S, Yang Y, Guo M,
Wang D, Luo Q and Xu L: Comprehensive circular RNA profiling
identifies CircFAM120A as a new biomarker of hypoxic lung
adenocarcinoma. Ann Transl Med. 7:4422019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen F, Huang C, Wu Q, Jiang L, Chen S and
Chen L: Circular RNAs expression profiles in plasma exosomes from
early-stage lung adenocarcinoma and the potential biomarkers. J
Cell Biochem. 121:2525–2533. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang C, Tan S, Liu WR, Lei Q, Qiao W, Wu
Y, Liu X, Cheng W, Wei YQ, Peng Y and Li W: RNA-Seq profiling of
circular RNA in human lung adenocarcinoma and squamous cell
carcinoma. Mol Cancer. 18:1342019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu XX, Yang YE, Liu X, Wang X, Liu XX and
Mai J: A two-circular RNA signature as a noninvasive diagnostic
biomarker for lung adenocarcinoma. J Transl Med. 17:502019.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Qiu M, Xia W, Chen R, Wang S, Xu Y, Ma Z,
Xu W, Zhang E, Wang J, Fang T, et al: The Circular RNA circPRKCI
promotes tumor growth in lung adenocarcinoma. Cancer Res.
78:2839–2851. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang L, Liang Y, Mao Q, Xia W, Chen B,
Shen H, Xu L, Jiang F and Dong G: Circular RNA circCRIM1 inhibits
invasion and metastasis in lung adenocarcinoma through the microRNA
(miR)-182/miR-93-leukemia inhibitory factor receptor pathway.
Cancer Sci. 110:2960–2972. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yao Y, Hua Q, Zhou Y and Shen H: CircRNA
has_circ_0001946 promotes cell growth in lung adenocarcinoma by
regulating miR-135a-5p/SIRT1 axis and activating Wnt/β-catenin
signaling pathway. Biomed Pharmacother. 111:1367–1375. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zuo Y, Shen W, Wang C, Niu N and Pu J:
Circular RNA Circ-ZNF609 promotes lung adenocarcinoma proliferation
by modulating miR-1224-3p/ETV1 signaling. Cancer Manag Res.
12:2471–2479. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kristensen LS, Andersen MS, Stagsted LVW,
Ebbesen KK, Hansen TB and Kjems J: The biogenesis, biology and
characterization of circular RNAs. Nat Rev Genet. 20:675–691. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Patop IL, Wüst S and Kadener S: Past,
present, and future of circRNAs. EMBO J. 38:e1008362019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bach DH, Lee SK and Sood AK: Circular RNAs
in cancer. Mol Ther Nucleic Acids. 16:118–129. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Du J, Zhang G, Qiu H, Yu H and Yuan W: The
Novel Circular RNA circ-CAMK2A enhances lung adenocarcinoma
metastasis by regulating the miR-615-5p/fibronectin 1 pathway. Cell
Mol Biol Lett. 24:722019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shangguan H, Feng H, Lv D, Wang J, Tian T
and Wang X: Circular RNA circSLC25A16 contributes to the glycolysis
of non-small-cell lung cancer through epigenetic modification. Cell
Death Dis. 11:4372020. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang N, Nan A, Chen L, Li X, Jia Y, Qiu
M, Dai X, Zhou H, Zhu J, Zhang H and Jiang Y: Circular RNA
circSATB2 promotes progression of non-small cell lung cancer cells.
Mol Cancer. 19:1012020. View Article : Google Scholar : View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ma D, Qin Y, Huang C, Chen Y, Han Z, Zhou
X and Liu H: Circular RNA ABCB10 promotes non-small cell lung
cancer progression by increasing E2F5 expression through sponging
miR-584-5p. Cell Cycle. 19:1611–1620. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Song X, Liang Y, Sang Y, Li Y, Zhang H,
Chen B, Du L, Liu Y, Wang L, Zhao W, et al: circHMCU promotes
proliferation and metastasis of breast cancer by sponging the let-7
family. Mol Ther Nucleic Acids. 20:518–533. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ma Y, Cong X, Zhang Y, Yin X, Zhu Z and
Xue Y: CircPIP5K1A facilitates gastric cancer progression via
miR-376c-3p/ZNF146 axis. Cancer Cell Int. 20:812020. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bai S, Wu Y, Yan Y, Shao S, Zhang J, Liu
J, Hui B, Liu R, Ma H, Zhang X and Ren J: Construct a
circRNA/miRNA/mRNA regulatory network to explore potential
pathogenesis and therapy options of clear cell renal cell
carcinoma. Sci Rep. 10:136592020. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu Y, Xu Y, Xiao F, Zhang J, Wang Y, Yao
Y and Yang J: Comprehensive analysis of a circRNA-miRNA-mRNA
network to reveal potential inflammation-related targets for
gastric adenocarcinoma. Mediators Inflamm. 2020:94356082020.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wei S, Dai M, Zhang C, Teng K, Wang F, Li
H, Sun W, Feng Z, Kang T, Guan X, et al: KIF2C: A novel link
between Wnt/β-catenin and mTORC1 signaling in the pathogenesis of
hepatocellular carcinoma. Protein Cell. 12:788–809. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li X, Huang W, Huang W, Wei T, Zhu W, Chen
G and Zhang J: Kinesin family members KIF2C/4A/10/11/14/18B/20A/23
predict poor prognosis and promote cell proliferation in
hepatocellular carcinoma. Am J Transl Res. 12:1614–1639.
2020.PubMed/NCBI
|
|
31
|
Gan H, Lin L, Hu N, Yang Y, Gao Y, Pei Y,
Chen K and Sun B: KIF2C exerts an oncogenic role in nonsmall cell
lung cancer and is negatively regulated by miR-325-3p. Cell Biochem
Funct. 37:424–431. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Bai Y, Xiong L, Zhu M, Yang Z, Zhao J and
Tang H: Co-expression network analysis identified KIF2C in
association with progression and prognosis in lung adenocarcinoma.
Cancer Biomark. 24:371–382. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Gao T, Yu L, Fang Z, Liu J, Bai C, Li S,
Xue R, Zhang L, Tan Z and Fan Z: KIF18B promotes tumor progression
in osteosarcoma by activating β-catenin. Cancer Biol Med.
17:371–386. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chung S, Suzuki H, Miyamoto T, Takamatsu
N, Tatsuguchi A, Ueda K, Kijima K, Nakamura Y and Matsuo Y:
Development of an orally-administrative MELK-targeting inhibitor
that suppresses the growth of various types of human cancer.
Oncotarget. 3:1629–1640. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Cao Y, Zhu W, Chen W, Wu J, Hou G and Li
Y: Prognostic value of BIRC5 in lung adenocarcinoma lacking EGFR,
KRAS, and ALK mutations by integrated bioinformatics analysis. Dis
Markers. 2019:54512902019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Shin SB, Jang HR, Xu R, Won JY and Yim H:
Active PLK1-driven metastasis is amplified by TGF-beta signaling
that forms a positive feedback loop in non-small cell lung cancer.
Oncogene. 39:767–785. 2020. View Article : Google Scholar : View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Nieto-Jimenez C, Galan-Moya EM,
Corrales-Sanchez V, Noblejas-Lopez MDM, Burgos M, Domingo B,
Montero JC, Gomez-Juarez M, Picazo-Martinez MG, Esparis-Ogando A,
et al: Inhibition of the mitotic kinase PLK1 overcomes therapeutic
resistance to BET inhibitors in triple negative breast cancer.
Cancer Lett. 491:50–59. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang P and He X: Oncogenic and prognostic
role of CKAP2L in hepatocellular carcinoma. Int J Clin Exp Pathol.
13:923–933. 2020.PubMed/NCBI
|
|
39
|
Xiong G, Li L, Chen X, Song S, Zhao Y, Cai
W and Peng J: Up-regulation of CKAP2L expression promotes lung
adenocarcinoma invasion and is associated with poor prognosis. Onco
Targets Ther. 12:1171–1180. 2019. View Article : Google Scholar : PubMed/NCBI
|
